IS2943B - Fínasteríðsamsetningar - Google Patents

Fínasteríðsamsetningar

Info

Publication number
IS2943B
IS2943B IS7888A IS7888A IS2943B IS 2943 B IS2943 B IS 2943B IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A IS 2943 B IS2943 B IS 2943B
Authority
IS
Iceland
Prior art keywords
fínasteríðsamsetningar
Prior art date
Application number
IS7888A
Other languages
English (en)
Other versions
IS7888A (is
Inventor
Fjalar Jóhannsson
Birkir Árnason
Original Assignee
Actavis Group Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Hf filed Critical Actavis Group Hf
Publication of IS7888A publication Critical patent/IS7888A/is
Publication of IS2943B publication Critical patent/IS2943B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS7888A 2002-11-22 2005-06-10 Fínasteríðsamsetningar IS2943B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
PCT/IS2003/000034 WO2004047798A2 (en) 2002-11-22 2003-11-21 Formulations of finasteride

Publications (2)

Publication Number Publication Date
IS7888A IS7888A (is) 2005-06-10
IS2943B true IS2943B (is) 2016-03-15

Family

ID=36700777

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
IS7888A IS2943B (is) 2002-11-22 2005-06-10 Fínasteríðsamsetningar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum

Country Status (5)

Country Link
US (1) US20060099251A1 (is)
EP (1) EP1575555B1 (is)
AU (1) AU2003302372A1 (is)
IS (2) IS6633A (is)
WO (1) WO2004047798A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
CN104586832B (zh) * 2007-09-10 2018-02-16 北京强新生物科技有限公司 用于癌症治疗的组合物和方法
CN103025159A (zh) 2010-03-19 2013-04-03 波士顿生物医学公司 靶向癌症干细胞的新方法
KR20180080368A (ko) 2010-11-22 2018-07-11 에너지네시스 바이오메디컬 컴퍼니 리미티드 모발 성장 촉진제
ES2784026T3 (es) 2010-12-15 2020-09-21 Energenesis Biomedical Co Ltd Uso no terapéutico de una composición para promover el crecimiento del cabello
KR20150139955A (ko) 2013-04-09 2015-12-14 보스톤 바이오메디칼, 인크. 암 치료에 사용하기 위한 2-아세틸나프토[2,3-b]푸란-4,9-디온
EP3002005A1 (en) * 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch
BR112019001225A2 (pt) * 2016-08-02 2019-04-30 Durect Corporation composições compreendendo sulfato de colesterol oxigenado e pelo menos um dentre polialquileno glicol, carboximetil celulose e polioxilglicerídeo
JP7106563B2 (ja) 2016-11-29 2022-07-26 スミトモ ファーマ オンコロジー, インコーポレイテッド ナフトフラン誘導体、その調製、および使用方法
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
CN108853047A (zh) * 2018-07-25 2018-11-23 江苏黄河药业股份有限公司 一种非那雄胺片及其制备方法
CN109453134A (zh) * 2018-12-03 2019-03-12 海南赛立克药业有限公司 一种含非那雄胺的药物组合物及其制备方法
GB2610163B (en) * 2021-08-12 2023-12-13 Netriver Systems Ltd Secure online exchange of digital identification

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
GB9717444D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
GB9717428D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
WO1999021534A1 (en) * 1997-10-27 1999-05-06 Merck Patent Gmbh Solid state solutions and dispersions of poorly water soluble drugs
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
US20060099251A1 (en) 2006-05-11
WO2004047798A3 (en) 2004-07-29
IS6633A (is) 2004-05-23
EP1575555A2 (en) 2005-09-21
IS7888A (is) 2005-06-10
EP1575555B1 (en) 2014-08-06
AU2003302372A8 (en) 2004-06-18
WO2004047798A2 (en) 2004-06-10
AU2003302372A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
DE50305852D1 (de) Einspritzventil
DE50310083D1 (de) Phthalocyaninpigmentzubereitungen
ATE427876T1 (de) Luftkissenboot
NO20043547L (no) Aza-arylpiperaziner
DE50212349D1 (de) Hirurgie
DE60310714D1 (de) Etonogestrelester
DE50305301D1 (de) Einspritzventil
DE50309536D1 (de) Fadenabsaugvorrichtung
DE50310481D1 (de) Röntgenstativ
ATA1572002A (de) Managementspleisskassette
DE50307971D1 (de) Gelenklager
DE50302660D1 (de) Stopfmachine
IS7888A (is) Fínasteríðsamsetningar
DE50301464D1 (de) Schraubensicherung
FI20021957A0 (fi) Lipeäruisku
DE50309499D1 (de) Librierwerkzeugen
ATA4142004A (de) Trägerverbau
ATE469773T1 (de) Zugöse
DE50305973D1 (de) Auffangwanne
DE50307628D1 (de) Getraenkehalter
DE50209283D1 (de) Tropfbewässerungsrohr
DE50303317D1 (de) Einschub-leistungsschalter
DE50308979D1 (de) Einspritzventil